<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180616040113N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-02-15</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Cognitive Behavioral Therapy (CBT) on sexual function and satisfaction of women with breast cancer</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of Cognitive Behavioral Therapy (CBT) on sexual function and satisfaction of women with breast cancer after mastectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31995</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: In order to intervention, the women will be divided into two groups of 21 participants as control and intervention groups in randomized blocking , using four blocks and a one to one allocation ratio by use RAS software. Then,the intervention and  control group's numbers will be held in envelops by block rows. The envelops will be closed and by Golestan Hospital's oncology secretary, they will be randomly assigned to eligible individuals in the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sexual function of women with breast cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Cognitive behavioral therapy result in more positive attitude toward sexual relation and improved sexual function disorder of couples. Cognitive-behavioral therapy is organized in 8 group sessions.The research samples are divided into 3 groups of 7 people. The sessions are organized by a researcher once a week for 90 minutes. Educational content includes:  Familiarity of members with each other and explaining the model of cognitive-behavioral therapy, Identifying their own thoughts and finding negative thoughts on sexual issues, types of beliefs and changing wrong beliefs, analysis of beneficial,  body image and  its changes during chemotherapy and mastectomy, relaxation training and imagination and confront negative excitements.Homework is given to the participants. After the end of eight sessions, the sexual function and sexual satisfaction questionnaires are completed by the intervention group. Intervention 2: Control group: Before starting treatment,  sexual function Index and sexual satisfaction questionnaires are completed by the control group.   Two months after starting treatment, the control group is contacted and  sexual function Index and sexual satisfaction questionnaires are again completed, A training session is given to them.Educational content includes body image and  its changes during chemotherapy and mastectomy, relaxation training and imagination and confront negative excitements.They are referred to consultant if they wish.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is there is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parvaneh Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery faculty, Ahvaz Jundishapur University of medical sciences, Golestan Ave, Ahvaz, Iran</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+98 61 3336 7543</telephone>
        <email>Mousavi-p@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Parvaneh Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery faculty, Ahvaz Jundishapur University of medical sciences, Golestan Ave, Ahvaz, Iran</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+98 613450547</telephone>
        <email>Mousavi-p@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women with breast cancer after mastectomy
Score less than 26.5 of female sexual function index questionnaire
Married
To have sexual relation with husband
To have minimum one child
After complete of chemotherapy course
Diagnosis of breast cancer 6 month till 5 years before present in research
Ability to attend in  group therapy session
Having at least elementary education
Score less than 75 of Larson sexual satisfaction questionnaire
Reproductive ages  18-49 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Pregnancy and lactation
Chronic diseases such as hypertension, diabetes and thyroid disease, and autoimmune diseases
Menopause
Taking antipsychotic drugs during the past 6 months
Psychiatric disorders
Use of Hormone Replacement Therapy (HRT)
Drug addiction or alcohol dependence or  psychoactive materials based on personal comments
Treatment another type of cancer or malignancy
Participate in concurrent therapy programs to reduce sexual problems and reduce other psychological problems
The occurrence of a unpleasant event during the last 6 months
Hysterectomy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C50</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm of breast</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Cognitive behavioral therapy result in more positive attitude toward sexual relation and improved sexual function disorder of couples. Cognitive-behavioral therapy is organized in 8 group sessions.The research samples are divided into 3 groups of 7 people. The sessions are organized by a researcher once a week for 90 minutes. Educational content includes:  Familiarity of members with each other and explaining the model of cognitive-behavioral therapy, Identifying their own thoughts and finding negative thoughts on sexual issues, types of beliefs and changing wrong beliefs, analysis of beneficial,  body image and  its changes during chemotherapy and mastectomy, relaxation training and imagination and confront negative excitements.Homework is given to the participants. After the end of eight sessions, the sexual function and sexual satisfaction questionnaires are completed by the intervention group.</i_keyword>
      <i_keyword>Control group: Before starting treatment,  sexual function Index and sexual satisfaction questionnaires are completed by the control group.   Two months after starting treatment, the control group is contacted and  sexual function Index and sexual satisfaction questionnaires are again completed, A training session is given to them.Educational content includes body image and  its changes during chemotherapy and mastectomy, relaxation training and imagination and confront negative excitements.They are referred to consultant if they wish.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual function  of women with breast cancer. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</prim_outcome>
      <prim_outcome>Sexual satisfaction. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Larson sexual satisfaction questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sexual desire. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
      <sec_outcome>Sexual arousal. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
      <sec_outcome>Vaginal Lubrication. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
      <sec_outcome>Orgasm. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
      <sec_outcome>Dyspareunia. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
      <sec_outcome>Sexual pleasure. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-06-09</approval_date>
        <contact_name>Ethics committee of Ahvaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nursing and Midwifery Ahvaz Jundishapur, Esfand Ave, Golestan Blvd, Ahvaz, Khuzestan Ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
